Updated Date: Wed, 15 Apr 2020 00:00:00 EDT
Updated Date: Wed, 15 Apr 2020 00:00:00 EDT
Novartis and Incyte’s Jakafi has had a whirlwind few weeks as it rolls into a late-stage trial as […]
Antimalarial hydroxychloroquine has raked in support as a potential wonder drug to treat COVID-19, with even President Donald […]
An inquiry into childbirth cases of “serious and potentially serious concern” at Shrewsbury and Telford Hospitals NHS Trust […]
The recent publication of an industry sponsored, open, non-randomised study of remdesivir in a heterogeneous patient population has […]
The European Medicines Agency’s pharmacovigilance risk assessment committee (PRAC) has recommended updating the product information for drugs containing […]
“Deep breath in … and out. Again, deep breath in … and out.”We tune in to patients’ breath […]
Like many people around the world just now, those living in the São Paulo neighbourhood of Paraisópolis are […]
Biogen may be the biopharma company whose employees have been most intimately affected by the COVID-19 pandemic. Aside from dozens […]